Asthma Clinical Trials in Montpellier
7 recruitingMontpellier, France
Showing 1–7 of 7 trials
Recruiting
Phase 3
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment
Eosinophilic Asthma
AstraZeneca400 enrolled157 locationsNCT06750289
Recruiting
Phase 3
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)
Asthma
AstraZeneca200 enrolled112 locationsNCT05692180
Recruiting
ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar
Chronic Spontaneous Urticaria (CSU)Allergic Asthma
Celltrion HealthCare France225 enrolled1 locationNCT07425639
Recruiting
Phase 2
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Asthma
Sanofi1,147 enrolled240 locationsNCT06676319
Recruiting
Phase 4
Predictive Signature of Benralizumab Response
Severe AsthmaAsthma; Eosinophilic
Nantes University Hospital220 enrolled20 locationsNCT04565483
Recruiting
Phase 3
REVErsing Airway Remodelling With Tezepelumab
Airway Remodelling, Asthmatic
University Hospital, Montpellier90 enrolled12 locationsNCT05651841
Recruiting
Not Applicable
Forced Oscillations Technique During a Metacholine Test in Children
Asthma in Children
University Hospital, Montpellier112 enrolled1 locationNCT05734261